BC
TYRA icon

Boxer Capital’s Tyra Biosciences TYRA Stock Holding History

Boxer Capital’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,448,359
Closed -$152M – 60
2024
Q3 		$152M Hold
6,448,359
– – 7.44% 2
2024
Q2 		$103M Hold
6,448,359
– – 5.43% 5
2024
Q1 		$106M Hold
6,448,359
– – 5.22% 4
2023
Q4 		$89.3M Hold
6,448,359
– – 4.45% 7
2023
Q3 		$88.8M Hold
6,448,359
– – 4.73% 4
2023
Q2 		$110M Hold
6,448,359
– – 5.09% 4
2023
Q1 		$104M Hold
6,448,359
– – 5.09% 6
2022
Q4 		$49M Hold
6,448,359
– – 2.58% 10
2022
Q3 		$56.7M Hold
6,448,359
– – 3.19% 9
2022
Q2 		$46.1M Hold
6,448,359
– – 2.92% 9
2022
Q1 		$69M Hold
6,448,359
– – 3.55% 9
2021
Q4 		$90.7M Buy
6,448,359
+125,000
+2% +$2.48M 3.52% 7
2021
Q3 		$111M Buy
+6,323,359
New +$121M 3.88% 5

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boxer Capital's TYRA Position: Q4 2024 in Review

Boxer Capital sold out of Tyra Biosciences (TYRA) in Q4 2024, closing a stake of 6,448,359 shares — an estimated $152M sold.

Boxer Capital first reported a position in TYRA in Q3 2021 and held it in 13 quarters. The position peaked at $152M in Q3 2024. 113 funds tracked by Wall St. Rank hold TYRA as of Q4 2024.

  • Boxer Capital reported no remaining Tyra Biosciences position as of Q4 2024 after selling out during the quarter.
  • Boxer Capital sold 6,448,359 Tyra Biosciences shares in Q4 2024, an estimated $152M.
  • Boxer Capital first reported a position in Tyra Biosciences in Q3 2021 and held it in 13 quarters.
  • Boxer Capital's Tyra Biosciences position peaked at $152M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Tyra Biosciences as of Q4 2024.

Based on Boxer Capital's 13F filing for Q4 2024.